Bioceres Crop Solutions (NASDAQ:BIOX) Announces Quarterly Earnings Results

Bioceres Crop Solutions (NASDAQ:BIOX) posted its quarterly earnings data on Monday. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.11), Zacks reports. The company had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same quarter in the previous year, the firm posted ($0.07) EPS.

Bioceres Crop Solutions Stock Up 7.5 %

Shares of NASDAQ BIOX traded up $0.50 during trading hours on Wednesday, hitting $7.16. The stock had a trading volume of 383,668 shares, compared to its average volume of 87,848. The company has a market capitalization of $450.01 million, a P/E ratio of 360.68 and a beta of 0.49. The firm’s 50-day moving average price is $7.73 and its two-hundred day moving average price is $9.85. Bioceres Crop Solutions has a 52 week low of $5.71 and a 52 week high of $14.05. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.86 and a current ratio of 1.24.

Analyst Ratings Changes

A number of brokerages have recently weighed in on BIOX. Canaccord Genuity Group dropped their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a report on Wednesday. Oppenheimer dropped their target price on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 21st. Roth Mkm dropped their target price on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Lake Street Capital dropped their target price on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Finally, Canaccord Genuity Group upgraded Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Four research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $12.13.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.